Developer docs
API playgroundTry for free, no card

Search company profiles

American Medical Systems

Full company profile

uuid00092jn

Namestring
American Medical Systems
Legal namestring
Boston Scientific Corporation
Company typeenum
Public
Founded yearint
1972
Descriptiontext

American Medical Systems (AMS) operates as a product brand within Boston Scientific's urology and pelvic health portfolio, specializing in implantable medical devices and procedural solutions for urological conditions. Founded in 1972 and headquartered in Minnetonka, Minnesota, AMS historically focused on devices to treat erectile dysfunction and incontinence and has since expanded under Boston Scientific ownership into a comprehensive urology platform spanning men's sexual health (AMS 700 Inflatable Penile Prosthesis with TENACIO Pump, Tactra Malleable Penile Prosthesis), urinary incontinence (AMS 800 Artificial Urinary Sphincter, Bulkamid Urethral Bulking Agent, Axonics Sacral Neuromodulation System), benign prostatic hyperplasia (GreenLight XPS Laser, Rezūm Water Vapor Therapy), kidney stone management (LithoVue Elite, Pulse 120H Holmium Laser with MOSES Technology, Swiss LithoClast Trilogy Max), prostate cancer (SpaceOAR Hydrogel), and pelvic floor reconstruction (Capio SLIM, Upsylon Y-Mesh).

The franchise generates revenue primarily through hardware sales of implantable and procedural devices to hospitals, surgical centers, and physician practices, with pricing conducted via quote-based procurement rather than public list pricing. Distribution is handled through Boston Scientific's global direct field sales organization, the Lab Agent ecommerce ordering portal, customer service support, and a layered professional and patient education ecosystem including the EDUCARE platform, UroAdvance program, and condition-specific patient websites (EDCure, FixIncontinence, ChooseYou, TreatMyBPH).

Strategic positioning has shifted from an independent medical device supplier to an integrated brand within a global medtech leader; the January 2024 acquisition of Axonics Inc. added sacral neuromodulation capabilities to the AMS offering, while a 2002 acquisition of CryoGen and ongoing integration of Valencia Technologies reflect a continuous M&A-driven portfolio expansion strategy. AMS now competes in fragmented but high-barrier specialty urology markets where regulatory clearances, surgeon training, and clinical evidence function as primary competitive moats.

Short descriptiontext

American Medical Systems is a urology medical device brand within Boston Scientific's portfolio, supplying implantable prostheses, artificial sphincters, neuromodulation systems, and procedural tools for erectile dysfunction, incontinence, BPH, kidney stone management, prostate cancer, and pelvic floor disorders to hospitals and surgical centers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersMinnetonka, United States
HQ citystring
Minnetonka
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
urology medical devices, pelvic health implants, penile prostheses, urinary incontinence devices, sacral neuromodulation systems
Industry3 codes
1Male Reproductive & Sexual Medicine (Andrology)
CodeHLAKAOADPrimaryYes
2Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
CodeHLAHADAAPrimaryNo
3Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits)
CodeHLAHADAMPrimaryNo
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Urology Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Implantable Medical Devices
TypeHardware Sales
Description

Sale of implantable urology and pelvic health devices including penile prostheses, artificial urinary sphincters, and related surgical products. Revenue generated from device sales to hospitals and surgical centers.

bostonscientific.com
2Neuromodulation Systems
TypeHardware Sales
Description

Sacral neuromodulation systems for treatment of urinary dysfunction, including the Axonics SNM System acquired by Boston Scientific in January 2024.

bostonscientific.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 11 records shown
1AMS (American Medical Systems)
Description

Product brand for urology devices including AMS 700 Inflatable Penile Prosthesis and AMS 800 Artificial Urinary Sphincter

bostonscientific.com
+10 more records
Core offering1 text field

American Medical Systems (AMS) develops, manufactures, and markets implantable medical devices and surgical tools for urology and pelvic health, including penile prostheses for erectile dysfunction, artificial urinary sphincters for incontinence, sacral neuromodulation systems, laser and water vapor therapies for BPH, kidney stone management systems, and pelvic floor reconstruction meshes. Products are sold to hospitals, surgical centers, and physician practices through Boston Scientific's global direct field sales channel.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Boston Scientific's urology portfolio is a comprehensive platform offering solutions across multiple urological conditions including kidney stone management, benign prostatic hyperplasia (BPH), erectile dysfunction, incontinence, pelvic organ prolapse, and prostate cancer. The portfolio spans treatment products (AMS 700™ Inflatable Penile Prosthesis with TENACIO™ Pump, Tactra™ Malleable Penile Prosthesis, AMS 800™ Artificial Urinary Sphincter, Bulkamid™ Urethral Bulking Agent, Axonics™ Sacral Neuromodulation System, SpaceOAR™ Hydrogel, Rezūm™ Water Vapor Therapy, GreenLight XPS™ Laser Therapy System) and surgical tools (Capio™ SLIM Suture Capturing Device, Upsylon™ Y-Mesh, Pulse™ 120H Holmium Laser System with MOSES Technology, LithoVue™ Elite System, Swiss LithoClast® Trilogy Max), supported by patient education platforms including ChooseYou, EDCure, FixIncontinence, and TreatMyBPH.

Product and service13 records
1AMS 700 Inflatable Penile Prosthesis with TENACIO Pump
2Tactra Malleable Penile Prosthesis
3AMS 800 Artificial Urinary Sphincter
4Bulkamid Urethral Bulking Agent
5Axonics Sacral Neuromodulation (SNM) System
6Capio SLIM Suture Capturing Device
7Upsylon Y-Mesh
8SpaceOAR Hydrogel
9GreenLight XPS Laser Therapy System
10Rezūm Water Vapor Therapy
11Pulse 120H Holmium Laser System with MOSES Technology
12LithoVue Elite System
13Swiss LithoClast Trilogy Max
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Boston Scientific acquired Axonics Inc. in January 2024 to strengthen its urology and pelvic health portfolio with sacral neuromodulation technologies. This acquisition integrated Axonics SNM System into AMS's product offerings for treatment of urinary retention and overactive bladder.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Convatec has a presence in continence care and urology consumables, competing indirectly with AMS in male urinary incontinence management.

TypeDirect peer
Description

Cook Medical offers a broad urology portfolio including ureteral stents, stone management devices, and continence products, directly competing with AMS in kidney stone management and core urology.

TypeBroad incumbent
Description

Medtronic is a broad medical device incumbent whose InterStim sacral neuromodulation system directly competes with the Axonics SNM system acquired by Boston Scientific; also active in pelvic health.

TypeDirect peer
Description

Coloplast is a direct peer specializing in ostomy, continence, and wound care, with significant overlap in urology (male incontinence, erectile dysfunction implants including Titan penile implant).

TypeDirect peer
Description

Laborie is a focused urology and pelvic health player offering urodynamics systems, continence care products, and male health devices, overlapping with AMS's diagnostics and incontinence portfolio.

TypeBroad incumbent
Description

Olympus is a broad endoscopy incumbent whose urology endoscopy and stone management systems compete with AMS's LithoVue Elite ureteroscope and kidney stone treatment portfolio.

TypeDirect peer
Description

Karl Storz is a leading manufacturer of endoscopes and instruments for urology, providing ureteroscopes and visualization systems that compete with LithoVue Elite in stone management procedures.

TypeRegional player
Description

Hollister provides continence care and ostomy products with urology offerings, serving as an indirect competitor in male incontinence product categories.

TypeBroad incumbent
Description

Stryker is a broad medical device incumbent with surgical instruments and urology-adjacent products, competing for hospital contracts and surgical capital equipment sales.

TypeBroad incumbent
Description

Becton Dickinson has a urology and surgical solutions division that competes with AMS in catheters, drainage systems, and certain urology procedure products.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

American Medical Systems

Urology Medical Devicesamericanmedicalsystems.com

American Medical Systems is a urology medical device brand within Boston Scientific's portfolio, supplying implantable prostheses, artificial sphincters, neuromodulation systems, and procedural tools for erectile dysfunction, incontinence, BPH, kidney stone management, prostate cancer, and pelvic floor disorders to hospitals and surgical centers globally.

What American Medical Systems does

American Medical Systems (AMS) operates as a product brand within Boston Scientific's urology and pelvic health portfolio, specializing in implantable medical devices and procedural solutions for urological conditions. Founded in 1972 and headquartered in Minnetonka, Minnesota, AMS historically focused on devices to treat erectile dysfunction and incontinence and has since expanded under Boston Scientific ownership into a comprehensive urology platform spanning men's sexual health (AMS 700 Inflatable Penile Prosthesis with TENACIO Pump, Tactra Malleable Penile Prosthesis), urinary incontinence (AMS 800 Artificial Urinary Sphincter, Bulkamid Urethral Bulking Agent, Axonics Sacral Neuromodulation System), benign prostatic hyperplasia (GreenLight XPS Laser, Rezūm Water Vapor Therapy), kidney stone management (LithoVue Elite, Pulse 120H Holmium Laser with MOSES Technology, Swiss LithoClast Trilogy Max), prostate cancer (SpaceOAR Hydrogel), and pelvic floor reconstruction (Capio SLIM, Upsylon Y-Mesh).

The franchise generates revenue primarily through hardware sales of implantable and procedural devices to hospitals, surgical centers, and physician practices, with pricing conducted via quote-based procurement rather than public list pricing. Distribution is handled through Boston Scientific's global direct field sales organization, the Lab Agent ecommerce ordering portal, customer service support, and a layered professional and patient education ecosystem including the EDUCARE platform, UroAdvance program, and condition-specific patient websites (EDCure, FixIncontinence, ChooseYou, TreatMyBPH).

Strategic positioning has shifted from an independent medical device supplier to an integrated brand within a global medtech leader; the January 2024 acquisition of Axonics Inc. added sacral neuromodulation capabilities to the AMS offering, while a 2002 acquisition of CryoGen and ongoing integration of Valencia Technologies reflect a continuous M&A-driven portfolio expansion strategy. AMS now competes in fragmented but high-barrier specialty urology markets where regulatory clearances, surgeon training, and clinical evidence function as primary competitive moats.

American Medical Systems firmographics

Firmographics
Name
American Medical Systems
Legal name
Boston Scientific Corporation
Website
https://americanmedicalsystems.com
Company type
Public
Founded year
1972
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
American Medical Systems is a urology medical device brand within Boston Scientific's portfolio, supplying implantable prostheses, artificial sphincters, neuromodulation systems, and procedural tools for erectile dysfunction, incontinence, BPH, kidney stone management, prostate cancer, and pelvic floor disorders to hospitals and surgical centers globally.
Ownership category
akta.pro rank

American Medical Systems industry classification

Industry
Product category
Urology Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD)
akta.pro secondary industries
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

Keywords

  • Urology medical devices
  • Pelvic health implants
  • Penile prostheses
  • Urinary incontinence devices
  • Sacral neuromodulation systems

Where American Medical Systems is headquartered

Location

Headquarters

HQ city
Minnetonka
HQ country
United States
HQ region
North America

Markets served

American Medical Systems business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Implantable Medical Devices: Sale of implantable urology and pelvic health devices including penile prostheses, artificial urinary sphincters, and related surgical products. Revenue generated from device sales to hospitals and surgical centers.
  2. Neuromodulation Systems: Sacral neuromodulation systems for treatment of urinary dysfunction, including the Axonics SNM System acquired by Boston Scientific in January 2024.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

American Medical Systems product offering

Product offering

Core offering

American Medical Systems (AMS) develops, manufactures, and markets implantable medical devices and surgical tools for urology and pelvic health, including penile prostheses for erectile dysfunction, artificial urinary sphincters for incontinence, sacral neuromodulation systems, laser and water vapor therapies for BPH, kidney stone management systems, and pelvic floor reconstruction meshes. Products are sold to hospitals, surgical centers, and physician practices through Boston Scientific's global direct field sales channel.

Product overview

Boston Scientific's urology portfolio is a comprehensive platform offering solutions across multiple urological conditions including kidney stone management, benign prostatic hyperplasia (BPH), erectile dysfunction, incontinence, pelvic organ prolapse, and prostate cancer. The portfolio spans treatment products (AMS 700™ Inflatable Penile Prosthesis with TENACIO™ Pump, Tactra™ Malleable Penile Prosthesis, AMS 800™ Artificial Urinary Sphincter, Bulkamid™ Urethral Bulking Agent, Axonics™ Sacral Neuromodulation System, SpaceOAR™ Hydrogel, Rezūm™ Water Vapor Therapy, GreenLight XPS™ Laser Therapy System) and surgical tools (Capio™ SLIM Suture Capturing Device, Upsylon™ Y-Mesh, Pulse™ 120H Holmium Laser System with MOSES Technology, LithoVue™ Elite System, Swiss LithoClast® Trilogy Max), supported by patient education platforms including ChooseYou, EDCure, FixIncontinence, and TreatMyBPH.

Differentiator

Problem solved

Functional benefit

Brands

  • AMS (American Medical Systems): Product brand for urology devices including AMS 700 Inflatable Penile Prosthesis and AMS 800 Artificial Urinary Sphincter
  • GreenLight XPS
  • Rezūm Water Vapor Therapy
  • SpaceOAR Hydrogel
  • LithoVue
  • Axonics
  • EDCure
  • FixIncontinence
  • ChooseYou
  • TreatMyBPH
  • UroAdvance

Products and services

  • AMS 700 Inflatable Penile Prosthesis with TENACIO Pump
  • Tactra Malleable Penile Prosthesis
  • AMS 800 Artificial Urinary Sphincter
  • Bulkamid Urethral Bulking Agent
  • Axonics Sacral Neuromodulation (SNM) System
  • Capio SLIM Suture Capturing Device
  • Upsylon Y-Mesh
  • SpaceOAR Hydrogel
  • GreenLight XPS Laser Therapy System
  • Rezūm Water Vapor Therapy
  • Pulse 120H Holmium Laser System with MOSES Technology
  • LithoVue Elite System
  • Swiss LithoClast Trilogy Max

Companies that use American Medical Systems

Customer profile

Segments5 records

Ideal customer profiles1 record

American Medical Systems technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

American Medical Systems partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Axonics Inc.coreStrategic or Co-development Partner · 1 January 2024Boston Scientific acquired Axonics Inc. in January 2024 to strengthen its urology and pelvic health portfolio with sacral neuromodulation technologies. This acquisition integrated Axonics SNM System into AMS's product offerings for treatment of urinary retention and overactive bladder.

Scale indicators2 records

Recent moves5 records

Expansion highlights6 records

American Medical Systems competitors and assessment

Company assessment

Regional players

  • Convatec: Convatec has a presence in continence care and urology consumables, competing indirectly with AMS in male urinary incontinence management.
  • Hollister Incorporated: Hollister provides continence care and ostomy products with urology offerings, serving as an indirect competitor in male incontinence product categories.

Direct peers

  • Cook Medical: Cook Medical offers a broad urology portfolio including ureteral stents, stone management devices, and continence products, directly competing with AMS in kidney stone management and core urology.
  • Coloplast: Coloplast is a direct peer specializing in ostomy, continence, and wound care, with significant overlap in urology (male incontinence, erectile dysfunction implants including Titan penile implant).
  • Laborie Medical Technologies: Laborie is a focused urology and pelvic health player offering urodynamics systems, continence care products, and male health devices, overlapping with AMS's diagnostics and incontinence portfolio.
  • Karl Storz: Karl Storz is a leading manufacturer of endoscopes and instruments for urology, providing ureteroscopes and visualization systems that compete with LithoVue Elite in stone management procedures.

Broad incumbents

  • Medtronic: Medtronic is a broad medical device incumbent whose InterStim sacral neuromodulation system directly competes with the Axonics SNM system acquired by Boston Scientific; also active in pelvic health.
  • Olympus Medical: Olympus is a broad endoscopy incumbent whose urology endoscopy and stone management systems compete with AMS's LithoVue Elite ureteroscope and kidney stone treatment portfolio.
  • Stryker: Stryker is a broad medical device incumbent with surgical instruments and urology-adjacent products, competing for hospital contracts and surgical capital equipment sales.
  • Becton Dickinson: Becton Dickinson has a urology and surgical solutions division that competes with AMS in catheters, drainage systems, and certain urology procedure products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

American Medical Systems social profiles

Digital presence

American Medical Systems financial estimates

Financial estimate

Revenue estimate

Valuation estimate

American Medical Systems leadership team

Management profile

Number of profiles

Profiles1 record

American Medical Systems subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

American Medical Systems funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

American Medical Systems M&A and investment

M&A and investment

M&A1 record

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American Medical Systems

What does American Medical Systems do?

American Medical Systems (AMS) develops, manufactures, and markets implantable medical devices and surgical tools for urology and pelvic health, including penile prostheses for erectile dysfunction, artificial urinary sphincters for incontinence, sacral neuromodulation systems, laser and water vapor therapies for BPH, kidney stone management systems, and pelvic floor reconstruction meshes. Products are sold to hospitals, surgical centers, and physician practices through Boston Scientific's global direct field sales channel.

Is American Medical Systems a public or private company?

American Medical Systems is a public company. It is classified as corporate owned and is currently operating.

When was American Medical Systems founded?

American Medical Systems was founded in 1972. It employs 5,001 to 10,000 people.

Where is American Medical Systems based?

American Medical Systems is headquartered in Minnetonka, United States, in the North America region.

How does American Medical Systems make money?

Two revenue lines are on record. Implantable Medical Devices are the primary driver. The others are neuromodulation Systems.

Who are American Medical Systems's main competitors?

Regional players on record are Convatec and Hollister Incorporated. Direct peers are Cook Medical, Coloplast, Laborie Medical Technologies and Karl Storz. Broad incumbents are Medtronic, Olympus Medical, Stryker and Becton Dickinson.

Does American Medical Systems have an API?

No public API is recorded for American Medical Systems.

What industry is American Medical Systems in?

American Medical Systems's product category is Urology Medical Devices. Its primary akta.pro industry code is HLAKAOAD, Male Reproductive & Sexual Medicine (Andrology), with a secondary code of HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NafcTake the Women And Incontinence SurveyThe FDA issued a Public Health Notification in October 2008 regarding complications associated with transvaginal surgical mesh used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI), followed by a July 2011 update noting that adverse events for POP mesh repair were not rare and questioning the device's effectiveness compared to non-mesh surgical repair. In September 2011, an FDA advisory panel recommended reclassifying transvaginal mesh for POP from Class II to the stricter Class III category while keeping mesh for SUI in Class II, and in January 2012 the FDA requested post-market surveillance studies for all previously approved vaginal mesh devices for POP and single-incision mini-sling devices for SUI. The article summarizes manufacturer presentations at the FDA hearings by a working group including American Medical Systems, C.R. Bard, Boston Scientific, and Ethicon Women's Health and Urology arguing for continued Class II classification.BioSpaceBoston Scientific Announces Pricing of €2.0 Billion of Senior NotesBoston Scientific Corporation, through its subsidiary American Medical Systems Europe B.V., priced a €2.0 billion public offering of senior notes due 2029 and 2032. The company intends to use the net proceeds primarily to finance the acquisition of Axonics, Inc. and pay related expenses, with any remaining funds used for general corporate purposes or debt repayment.BostonscientificBoston Scientific announces pricing of €2.0 billion of senior notesBoston Scientific has priced a €2.0 billion public offering of senior notes, consisting of €750 million due in 2029 and €1.25 billion due in 2032, issued through its subsidiary American Medical Systems Europe B.V. The company intends to use the net proceeds primarily to finance the previously announced acquisition of Axonics, Inc., along with related fees and expenses. The transaction is expected to close on February 27, 2024, subject to customary conditions.DrugwatchEndo International and American Medical SystemsEndo International is a pharmaceutical company primarily focused on pain management, with Percocet among its most recognized products, which expanded into urology and medical devices through the 2011 acquisition of American Medical Systems. Three years after the acquisition, Endo faced nearly $1 billion in lawsuits concerning an allegedly defective pelvic mesh device manufactured by AMS.PR NewswireBoston Scientific Announces Completion of €3.0 Billion Offering of Senior NotesBoston Scientific Corporation completed a €3.0 billion public offering of senior notes through its subsidiary American Medical Systems Europe B.V., with maturities ranging from 2025 to 2034. The company intends to use the net proceeds primarily to fund a previously announced tender offer for up to $2.5 billion in existing senior notes and to redeem specific maturing bonds not purchased in the tender. Any remaining proceeds will be allocated toward repaying other indebtedness and general corporate purposes.FinSMEsNxThera Completes $12.6M Series B Equity FinancingNxThera completed a $12.6M Series B equity financing led by American Medical Systems, with participation from existing investors. The company will use the funds to initiate a pivotal BPH clinical study outside the U.S. and obtain CE mark approval for the European Economic Area.GlobeNewswire"BSD Medical Leading the Way for New Entrepreneurial Front" - Utah Business MagazineBSD Medical Corp. reported that Utah Business Magazine featured its thermal technology innovations, including the TherMatrx system for treating enlarged prostate. The sale of TherMatrx to American Medical Systems provided capital for further thermal therapy development. The company now aims to pursue cancer and benign condition treatments.